L-Tyrosine.

The body builds thyroid hormone by attaching iodine atoms to tyrosine, then joining those iodinated tyrosines into T3 and T4. Tyrosine supplies the backbone and iodine supplies the atoms that make it active, so the two together are the raw materials for normal thyroid hormone production.

Tyrosine hydroxylase, the first and rate-limiting enzyme that starts converting tyrosine into dopamine's precursor L-DOPA, carries an iron atom in its active site and cannot run the step without it. Iron availability therefore paces how readily the body moves tyrosine down the catecholamine pathway.

After tyrosine is converted to L-DOPA, the enzyme that turns L-DOPA into dopamine (aromatic amino acid decarboxylase) works only with vitamin B6 in its active PLP form. B6 is the cofactor that lets that decarboxylation step proceed, supporting the normal conversion of tyrosine into dopamine.

Copper is the metal built into dopamine beta-hydroxylase, the enzyme that converts dopamine into norepinephrine one step further along the pathway that starts with tyrosine. That conversion depends on copper, so copper supports the normal production of norepinephrine from tyrosine-derived dopamine.

The step that converts dopamine to noradrenaline runs on a copper enzyme that needs ascorbate to keep its copper reduced. Tyrosine supplies the substrate and vitamin C keeps that step turning.

Phenylalanine hydroxylase converts phenylalanine directly into tyrosine. Phenylalanine sits one step upstream of the whole catecholamine route.

The L-form is hydroxylated to tyrosine, feeding the same catecholamine route from one step upstream. The pairing supplies the pathway at two consecutive points.

Thyroid hormone is built on iodinated tyrosine residues, and the deiodinase enzymes that activate it are selenoproteins. Tyrosine and iodine supply the structure while selenium handles the conversion.

S-adenosyl methionine donates the methyl group that converts noradrenaline to adrenaline and is also used to inactivate catecholamines. Methyl supply shapes what happens after tyrosine.

Betaine remethylates homocysteine back to methionine, replenishing the S-adenosyl methionine used in catecholamine methylation. It keeps the methyl pool behind that step stocked.

Tyrosine hydroxylase needs tetrahydrobiopterin, whose salvage uses dihydrofolate reductase, and folate also refills the methyl pool used downstream. Both touchpoints sit on the catecholamine route.

Tyrosine and tryptophan compete for the same large neutral amino acid carrier into the brain and for aromatic amino acid decarboxylase afterwards. A large dose of one lowers central delivery of the other.

5-HTP and the tyrosine-derived L-dopa are both handled by aromatic amino acid decarboxylase, so heavy use of one draws on the shared enzyme and its B6 cofactor. Formulators balance the two rather than loading one alone.

Branched-chain amino acids compete with tyrosine at the large neutral amino acid carrier at the brain barrier. A large leucine dose lowers how much tyrosine reaches central tissue.

Valine uses the same large neutral amino acid carrier tyrosine needs to cross into the brain. Taken together at high dose they compete for that transport.

Mucuna carries L-dopa, which is the product of the tyrosine hydroxylase step. It enters the catecholamine route past the point that usually limits it.

Tyrosine supplies catecholamine substrate while theanine raises alpha activity and lowers arousal. Formulas combine them for focus without the restless feel.

Caffeine raises catecholamine signalling and turnover, and tyrosine is the substrate those transmitters are built from. Pairing substrate with a stimulus is long-standing formulation practice.

Zinc takes part in thyroid hormone metabolism and in the nuclear receptor that reads it, downstream of the iodinated tyrosine backbone. It sits on the same axis tyrosine and iodine feed.

Tyrosine crosses the blood-brain barrier on the LAT1 carrier, which it shares with tryptophan, the branched-chain amino acids, phenylalanine, methionine and histidine. A whey protein serving delivers all of those at once, so brain tyrosine uptake depends on the ratio of tyrosine to the sum of its competitors, not on the absolute amount. Taking free tyrosine inside a large mixed protein load flattens that ratio. This is transport competition, well characterised, and it argues for spacing rather than against either ingredient.

Isoleucine is one of the branched-chain amino acids that compete directly with tyrosine at LAT1. Supplemental branched-chain amino acids taken at the same time as tyrosine lower the plasma tyrosine ratio that governs brain entry. Neither is thereby wasted; the timing is what changes. Stated as a transport interaction, not a claim about performance.

Tyrosine hydroxylase, the rate-limiting step toward dopamine, requires tetrahydrobiopterin as cofactor, and 5-methyltetrahydrofolate can act as an alternative electron donor supporting pterin recycling. Modelling of the tyrosine hydroxylase pathway shows how strongly output tracks tetrahydrobiopterin availability rather than substrate alone. The folate connection is a cofactor-regeneration link, not a demonstrated additive effect on any endpoint in people.

Histidine and L-tyrosine were added together to an oocyte maturation medium in a buffalo in vitro study and developmental outcomes were tracked. Both amino acids also share the LAT1 carrier, so a systemic pairing has a competition side as well. Nothing here was measured in a person taking either by mouth. Kept at Early and labelled as non-human in vitro work.

Gut bacteria metabolise aromatic amino acids, and a paediatric inulin study in children with excess body weight reported changes in microbiota-derived metabolites related to brain function, with tyrosine-pathway metabolites among those measured. The direction of interest is what a fermentable fibre does to how much aromatic amino acid survives the colon. Tyrosine was a measured metabolite there, not the intervention. This is a metabolite association, not an outcome.

Tyrosine supplies the substrate for catecholamine synthesis under conditions that deplete it, while rhodiola preparations are used for stress load through a different and less mechanistically resolved route. Products pair them for that reason. No trial of the combination is in this candidate set, so the pairing rests on formulation rationale. Early confidence is the honest label.